165 related articles for article (PubMed ID: 23508039)
1. Paraoxonase 1 activities, regulation, and interactions with atherosclerotic lesion.
Aviram M; Vaya J
Curr Opin Lipidol; 2013 Aug; 24(4):339-44. PubMed ID: 23508039
[TBL] [Abstract][Full Text] [Related]
2. Variation in paraoxonase-1 activity and atherosclerosis.
Soran H; Younis NN; Charlton-Menys V; Durrington P
Curr Opin Lipidol; 2009 Aug; 20(4):265-74. PubMed ID: 19550323
[TBL] [Abstract][Full Text] [Related]
3. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
Rosenblat M; Karry R; Aviram M
Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase 1 interactions with HDL, antioxidants and macrophages regulate atherogenesis - a protective role for HDL phospholipids.
Efrat M; Aviram M
Adv Exp Med Biol; 2010; 660():153-66. PubMed ID: 20221878
[TBL] [Abstract][Full Text] [Related]
5. Paraoxonase, a cardioprotective enzyme: continuing issues.
Getz GS; Reardon CA
Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
[TBL] [Abstract][Full Text] [Related]
6. Human carotid plaque phosphatidylcholine specifically interacts with paraoxonase 1, increases its activity, and enhances its uptake by macrophage at the expense of its binding to HDL.
Cohen E; Aviram M; Khatib S; Artoul F; Rabin A; Mannheim D; Karmeli R; Salamon T; Vaya J
Free Radic Biol Med; 2014 Nov; 76():14-24. PubMed ID: 25091896
[TBL] [Abstract][Full Text] [Related]
7. S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity.
Rozenberg O; Aviram M
Biochem Biophys Res Commun; 2006 Dec; 351(2):492-8. PubMed ID: 17070779
[TBL] [Abstract][Full Text] [Related]
8. Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects.
Tavori H; Aviram M; Khatib S; Musa R; Nitecki S; Hoffman A; Vaya J
Free Radic Biol Med; 2009 Mar; 46(5):607-15. PubMed ID: 19103284
[TBL] [Abstract][Full Text] [Related]
9. The effect of HDL-bound and free PON1 on copper-induced LDL oxidation.
Bayrak A; Bayrak T; Bodur E; Kılınç K; Demirpençe E
Chem Biol Interact; 2016 Sep; 257():141-6. PubMed ID: 27510818
[TBL] [Abstract][Full Text] [Related]
10. HDL3 stimulates paraoxonase 1 antiatherogenic catalytic and biological activities in a macrophage model system: in vivo and in vitro studies.
Rosenblat M; Volkova N; Aviram M
Biofactors; 2014; 40(5):536-45. PubMed ID: 25230879
[TBL] [Abstract][Full Text] [Related]
11. Systemic inflammation, intestine, and paraoxonase-1.
Vakili L; Navab KD; Shabihkhani M; Pourtabatabaei N; Vazirian S; Barseghian Z; Seyedali S; Hough G
Adv Exp Med Biol; 2014; 824():83-8. PubMed ID: 25038995
[TBL] [Abstract][Full Text] [Related]
12. How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae.
Soran H; Schofield JD; Liu Y; Durrington PN
Curr Opin Lipidol; 2015 Aug; 26(4):247-56. PubMed ID: 26103614
[TBL] [Abstract][Full Text] [Related]
13. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
14. Macrophage paraoxonase 1 (PON1) binding sites.
Efrat M; Aviram M
Biochem Biophys Res Commun; 2008 Nov; 376(1):105-10. PubMed ID: 18762170
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase 1 protects macrophages from atherogenicity of a specific triglyceride isolated from human carotid lesion.
Tavori H; Aviram M; Khatib S; Musa R; Mannheim D; Karmeli R; Vaya J
Free Radic Biol Med; 2011 Jul; 51(1):234-42. PubMed ID: 21530644
[TBL] [Abstract][Full Text] [Related]
16. Paraoxonase 1 attenuates human plaque atherogenicity: relevance to the enzyme lactonase activity.
Tavori H; Vaya J; Aviram M
Adv Exp Med Biol; 2010; 660():99-111. PubMed ID: 20221874
[TBL] [Abstract][Full Text] [Related]
17. Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins.
Malle E; Marsche G; Panzenboeck U; Sattler W
Arch Biochem Biophys; 2006 Jan; 445(2):245-55. PubMed ID: 16171772
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase-1: Characteristics and Role in Atherosclerosis and Carotid Artery Disease.
Lioudaki S; Verikokos C; Kouraklis G; Ioannou C; Chatziioannou E; Perrea D; Klonaris C
Curr Vasc Pharmacol; 2019; 17(2):141-146. PubMed ID: 29189170
[TBL] [Abstract][Full Text] [Related]
19. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
[TBL] [Abstract][Full Text] [Related]
20. Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action.
Nguyen SD; Sok DE
Free Radic Res; 2003 Dec; 37(12):1319-30. PubMed ID: 14753756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
